- Home
- UMH vs NKTR Comparison
UMH vs NKTR Comparison
Compare UMH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMH
- NKTR
- Stock Information
- Founded
- UMH 1968
- NKTR 1990
- Country
- UMH United States
- NKTR United States
- Employees
- UMH N/A
- NKTR N/A
- Industry
- UMH Real Estate Investment Trusts
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- UMH Real Estate
- NKTR Health Care
- Exchange
- UMH Nasdaq
- NKTR Nasdaq
- Market Cap
- UMH 1.3B
- NKTR 1.2B
- IPO Year
- UMH N/A
- NKTR 1994
- Fundamental
- Price
- UMH $14.08
- NKTR $57.96
- Analyst Decision
- UMH Buy
- NKTR Strong Buy
- Analyst Count
- UMH 2
- NKTR 6
- Target Price
- UMH $17.75
- NKTR $91.67
- AVG Volume (30 Days)
- UMH 747.5K
- NKTR 1.2M
- Earning Date
- UMH 11-03-2025
- NKTR 11-06-2025
- Dividend Yield
- UMH 6.37%
- NKTR N/A
- EPS Growth
- UMH N/A
- NKTR N/A
- EPS
- UMH 0.13
- NKTR N/A
- Revenue
- UMH $250,046,000.00
- NKTR $74,934,000.00
- Revenue This Year
- UMH $6.77
- NKTR N/A
- Revenue Next Year
- UMH $5.32
- NKTR N/A
- P/E Ratio
- UMH $110.51
- NKTR N/A
- Revenue Growth
- UMH 8.49
- NKTR N/A
- 52 Week Low
- UMH $14.09
- NKTR $6.48
- 52 Week High
- UMH $20.42
- NKTR $62.95
- Technical
- Relative Strength Index (RSI)
- UMH 27.26
- NKTR 65.18
- Support Level
- UMH $14.39
- NKTR $57.50
- Resistance Level
- UMH $14.79
- NKTR $62.82
- Average True Range (ATR)
- UMH 0.29
- NKTR 3.73
- MACD
- UMH -0.04
- NKTR -0.77
- Stochastic Oscillator
- UMH 0.39
- NKTR 56.85
About UMH UMH Properties Inc.
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.